Patient Derived Xenograft Models Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Patient Derived Xenograft Models market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.9% during the forecast period.

    This report presents the market size and development trends by detailing the Patient Derived Xenograft Models market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Patient Derived Xenograft Models market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Patient Derived Xenograft Models industry and will help you to build a panoramic view of the industrial development.

    Patient Derived Xenograft Models Market, By Type:

    • Mice Models

    • Rat Models

    Patient Derived Xenograft Models Market, By Application:

    • Pharmaceutical & Biotechnology Companies

    • Contract Research Organizations

    • Academic & Research Institutions

    Some of the leading players are as follows:

    • Horizon Discovery Group PLC (UK)

    • ONCODESIGN (France)

    • WuXi AppTec (China)

    • Explora BioLabs (US)

    • Xentech (France)

    • EPO Berlin-Buch GmBH (Germany)

    • The Jackson Laboratory (US)

    • Urolead (France)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Patient Derived Xenograft Models Market

    • 1.3 Market Segment by Type

      • 1.3.1 Mice Models

      • 1.3.2 Rat Models

    • 1.4 Market Segment by Application

      • 1.4.1 Pharmaceutical & Biotechnology Companies

      • 1.4.2 Contract Research Organizations

      • 1.4.3 Academic & Research Institutions

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Patient Derived Xenograft Models Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Patient Derived Xenograft Models Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Patient Derived Xenograft Models Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Patient Derived Xenograft Models Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Patient Derived Xenograft Models Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Patient Derived Xenograft Models by Major Types

      • 3.4.1 Mice Models

      • 3.4.2 Rat Models

    4 Segmentation of Patient Derived Xenograft Models Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Patient Derived Xenograft Models by Major End-Users

      • 4.4.1 Pharmaceutical & Biotechnology Companies

      • 4.4.2 Contract Research Organizations

      • 4.4.3 Academic & Research Institutions

    5 Market Analysis by Major Regions

    • 5.1 Global Patient Derived Xenograft Models Production Analysis by Top Regions

    • 5.2 Global Patient Derived Xenograft Models Consumption Analysis by Top Regions

    • 5.3 Global Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

    6 Product Circulation of Patient Derived Xenograft Models Market among Top Countries

    • 6.1 Top 5 Export Countries in Patient Derived Xenograft Models Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Patient Derived Xenograft Models Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Patient Derived Xenograft Models Landscape Analysis

    • 7.1 North America Patient Derived Xenograft Models Landscape Analysis by Top Countries

      • 7.1.1 United States Patient Derived Xenograft Models Market Volume and Growth Rate

      • 7.1.2 Canada Patient Derived Xenograft Models Market Volume and Growth Rate

      • 7.1.3 Mexico Patient Derived Xenograft Models Market Volume and Growth Rate

    8. Europe Patient Derived Xenograft Models Landscape Analysis

    • 8.1 Europe Patient Derived Xenograft Models Landscape Analysis by Major Types

    • 8.2 Europe Patient Derived Xenograft Models Landscape Analysis by Major End-Users

    • 8.3 Europe Patient Derived Xenograft Models Landscape Analysis by Top Countries

      • 8.3.1 Germany Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.2 UK Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.3 France Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.4 Italy Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.5 Spain Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.6 Belgium Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.7 Poland Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.8 Russia Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.9 Turkey Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.10 Netherlands Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.11 Portugal Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.12 Denmark Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.13 Finland Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.14 Iceland Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.15 Norway Patient Derived Xenograft Models Market Volume and Growth Rate

      • 8.3.16 Sweden Patient Derived Xenograft Models Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Patient Derived Xenograft Models Landscape Analysis

    • 9.1 Asia Pacific Patient Derived Xenograft Models Landscape Analysis by Top Countries

      • 9.1.1 China Patient Derived Xenograft Models Market Volume and Growth Rate

      • 9.1.2 Japan Patient Derived Xenograft Models Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Patient Derived Xenograft Models Market Volume and Growth Rate

      • 9.1.4 India Patient Derived Xenograft Models Market Volume and Growth Rate

      • 9.1.5 ASEAN Patient Derived Xenograft Models Market Volume and Growth Rate

      • 9.1.6 South Korea Patient Derived Xenograft Models Market Volume and Growth Rate

    10 LAMEA Patient Derived Xenograft Models Landscape Analysis

    • 10.1 LAMEA Patient Derived Xenograft Models Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Patient Derived Xenograft Models Market Volume and Growth Rate

      • 10.1.2 Brazil Patient Derived Xenograft Models Market Volume and Growth Rate

      • 10.1.3 North Africa Patient Derived Xenograft Models Market Volume and Growth Rate

      • 10.1.4 South Africa Patient Derived Xenograft Models Market Volume and Growth Rate

      • 10.1.5 Argentina Patient Derived Xenograft Models Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Horizon Discovery Group PLC (UK)

      • 11.1.1 Horizon Discovery Group PLC (UK) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 ONCODESIGN (France)

      • 11.2.1 ONCODESIGN (France) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 WuXi AppTec (China)

      • 11.3.1 WuXi AppTec (China) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Explora BioLabs (US)

      • 11.4.1 Explora BioLabs (US) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Xentech (France)

      • 11.5.1 Xentech (France) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 EPO Berlin-Buch GmBH (Germany)

      • 11.6.1 EPO Berlin-Buch GmBH (Germany) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 The Jackson Laboratory (US)

      • 11.7.1 The Jackson Laboratory (US) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Urolead (France)

      • 11.8.1 Urolead (France) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 89 Figures and 168 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Mice Models

    • Figure Market Size and Growth Rate of Rat Models

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Contract Research Organizations

    • Figure Market Size and Growth Rate of Academic & Research Institutions

    • Figure North America Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure United States Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure UK Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure France Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure China Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure India Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Patient Derived Xenograft Models Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Patient Derived Xenograft Models Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Patient Derived Xenograft Models

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Patient Derived Xenograft Models by Different Types from 2014 to 2026

    • Table Consumption Share of Patient Derived Xenograft Models by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Mice Models

    • Figure Market Size and Growth Rate of Rat Models

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Patient Derived Xenograft Models by Different End-Users from 2014 to 2026

    • Table Consumption Share of Patient Derived Xenograft Models by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Pharmaceutical & Biotechnology Companies

    • Figure Market Size and Growth Rate of Contract Research Organizations

    • Figure Market Size and Growth Rate of Academic & Research Institutions

    • Table Global Patient Derived Xenograft Models Production by Major Regions

    • Table Global Patient Derived Xenograft Models Production Share by Major Regions

    • Table Global Patient Derived Xenograft Models Consumption by Major Regions

    • Table Global Patient Derived Xenograft Models Consumption Share by Major Regions

    • Table North America Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

    • Table Europe Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

    • Table LAMEA Patient Derived Xenograft Models Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Patient Derived Xenograft Models Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Patient Derived Xenograft Models Consumption by Major Countries from 2014 to 2026

    • Table North America Patient Derived Xenograft Models Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Patient Derived Xenograft Models Consumption Share by Major Countries in 2014

    • Figure North America Patient Derived Xenograft Models Consumption Share by Major Countries in 2018

    • Figure North America Patient Derived Xenograft Models Consumption Share by Major Countries in 2026

    • Figure United States Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Patient Derived Xenograft Models Consumption by Types from 2014 to 2026

    • Table Europe Patient Derived Xenograft Models Consumption Share by Types from 2014 to 2026

    • Table Europe Patient Derived Xenograft Models Consumption by End-Users from 2014 to 2026

    • Table Europe Patient Derived Xenograft Models Consumption Share by End-Users from 2014 to 2026

    • Table Europe Patient Derived Xenograft Models Consumption by Major Countries from 2014 to 2026

    • Table Europe Patient Derived Xenograft Models Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure France Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Patient Derived Xenograft Models Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Patient Derived Xenograft Models Consumption Share by Major Countries from 2014 to 2026

    • Figure China Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure India Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Patient Derived Xenograft Models Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Patient Derived Xenograft Models Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Patient Derived Xenograft Models Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Horizon Discovery Group PLC (UK)

    • Figure Sales and Growth Rate Analysis of Horizon Discovery Group PLC (UK)

    • Figure Revenue and Market Share Analysis of Horizon Discovery Group PLC (UK)

    • Table Product and Service Introduction of Horizon Discovery Group PLC (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ONCODESIGN (France)

    • Figure Sales and Growth Rate Analysis of ONCODESIGN (France)

    • Figure Revenue and Market Share Analysis of ONCODESIGN (France)

    • Table Product and Service Introduction of ONCODESIGN (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of WuXi AppTec (China)

    • Figure Sales and Growth Rate Analysis of WuXi AppTec (China)

    • Figure Revenue and Market Share Analysis of WuXi AppTec (China)

    • Table Product and Service Introduction of WuXi AppTec (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Explora BioLabs (US)

    • Figure Sales and Growth Rate Analysis of Explora BioLabs (US)

    • Figure Revenue and Market Share Analysis of Explora BioLabs (US)

    • Table Product and Service Introduction of Explora BioLabs (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xentech (France)

    • Figure Sales and Growth Rate Analysis of Xentech (France)

    • Figure Revenue and Market Share Analysis of Xentech (France)

    • Table Product and Service Introduction of Xentech (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EPO Berlin-Buch GmBH (Germany)

    • Figure Sales and Growth Rate Analysis of EPO Berlin-Buch GmBH (Germany)

    • Figure Revenue and Market Share Analysis of EPO Berlin-Buch GmBH (Germany)

    • Table Product and Service Introduction of EPO Berlin-Buch GmBH (Germany)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Jackson Laboratory (US)

    • Figure Sales and Growth Rate Analysis of The Jackson Laboratory (US)

    • Figure Revenue and Market Share Analysis of The Jackson Laboratory (US)

    • Table Product and Service Introduction of The Jackson Laboratory (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Urolead (France)

    • Figure Sales and Growth Rate Analysis of Urolead (France)

    • Figure Revenue and Market Share Analysis of Urolead (France)

    • Table Product and Service Introduction of Urolead (France)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.